Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2026 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2026 Earnings Call Transcript May 4, 2026Vertex Pharmaceuticals Incorporated beats earnings expectations.
Vertex Pharmaceuticals Inc / Ma (VRTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 638,950 | $285,316,733 | +8% | 0.15% |
| 2. | Renaissance Technologies Jim Simons | 421,688 | $188,300,560 | -17% | 0.29% |
| 3. | Hudson Bay Capital Management Sander Gerber | 45,000 | $20,094,300 | -73% | 0.07% |
| 4. | Rhenman & Partners Asset Management Henrik Rhenman | 43,485 | $19,417,792 | +27% | 2.4% |
| 5. | Bailard Inc Thomas Bailard | 37,862 | $16,907,047 | +12% | 0.39% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $389.95 | 5,710 | $2,226,614.50 | 115,968 | 2025-08-06 | Filing | |
| $389.08 | 4,290 | $1,669,153.20 | 110,258 | 2025-08-06 | Filing | |
| $389.84 | 3,366 | $1,312,201.44 | 45,000 | 2025-08-06 | Filing | |
| $389.36 | 1,634 | $636,214.24 | 41,634 | 2025-08-06 | Filing | |
| $196.34 | 4,243 | $833,070.62 | 73,754 | 2021-08-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $450.00 | 6,988 | $3,144,600.00 | 26,088 | 2026-05-12 | Filing | |
| $425.02 | 1,104 | $469,222.08 | 20,729 | 2026-05-01 | Filing | |
| $423.73 | 318 | $134,746.14 | 4,924 | 2026-05-04 | Filing | |
| $449.17 | 978 | $439,288.26 | 21,833 | 2026-04-01 | Filing | |
| $450.95 | 2,329 | $1,050,262.55 | 33,076 | 2026-03-27 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 25,368,124 | $11,327,759,436 | 1.55% | |
| 2. | 23,969,517 | $10,703,348,322 | 0.19% | |
| 3. | 21,125,964 | $9,433,408,963 | 1.46% | |
| 4. | 16,512,810 | $7,373,630,177 | 0.18% | |
| 5. | 7,033,156 | $3,116,813,989 | 0.2% |
News See All
Vertex (VRTX) Named Top Biotech Pick for 2026 by BofA
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the most profitable biotech stocks to buy now.
10 Most Profitable Biotech Stocks to Buy Now
Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, surpassing both the S&P 500 and the broader market index, and ending 2025 with its...
Vertex Pharmaceuticals Incorporated (VRTX) PT Nudged Higher as RBC Updates Biotech Sector Outlook
TheFly reported on April 7 that RBC Capital Markets slightly increased its price target on VRTX from $541 to $543 while maintaining an Outperform rating.
Top 10 AI-Powered Biotech Stocks to Buy Right Now
Franklin Equity reported on February 16 that, following a protracted period of uncertainty in the previous year, the biotechnology sector has entered 2026 on a firmer and more stable foundation.
Jim Cramer’s 16 Stock Calls, Including NVIDIA, Coterra, and Honeywell
In this article, we will look at Jim Cramer's recent stock calls on Mad Money.
Top 10 Reddit Stocks That Will Skyrocket
Even before tensions between Iran and the US picked up, retail investors were already moving toward energy stocks.
15 Set-It-and-Forget-It Stocks to Buy in 2026
Long-term wealth building requires choosing investments that could withstand various economic conditions.
Is Vertex Pharmaceuticals Incorporated (VRTX) A Good Stock To Buy Now?
Is VRTX a good stock to buy? We came across a bullish thesis on Vertex Pharmaceuticals Incorporated on r/AIPortfolios by manojs. In this article, we will summarize the bulls’ thesis on VRTX.
Truist Raises Vertex (VRTX) Price Target Following Phase 3 Trial Results
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best high profit margin stocks to buy.
Hedge Fund Resource Center